<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Vaccine Research</title>
<title_fa>Vaccine Research</title_fa>
<short_title>vacres</short_title>
<subject>Medical Sciences</subject>
<web_url>http://vacres.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2383-2819</journal_id_issn>
<journal_id_issn_online>2423-4923</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61186/vacres</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy</title>
	<subject_fa>Vaccine development, efficacy and safety evaluation</subject_fa>
	<subject>Vaccine development, efficacy and safety evaluation</subject>
	<content_type_fa>Review article</content_type_fa>
	<content_type>Review article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>The bacillus Calmette‐Gu&amp;eacute;rin (BCG) vaccine against pulmonary tuberculosis (TB) remains with poor protective efficacy. However BCG is the only licensed vaccine against human TB. This review discusses the main research progress in the field of TB vaccine development and will summarize the current status, and main challenges for the development of a safer and more efficient TB vaccine.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>,BCG,global health,clinical trials,tuberculosis,vaccine</keyword>
	<start_page>29</start_page>
	<end_page>32</end_page>
	<web_url>http://vacres.pasteur.ac.ir/browse.php?a_code=A-10-759-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Patricia</first_name>
	<middle_name></middle_name>
	<last_name>Méndez-Samperio</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>pmendezsamperio@gmail.com</email>
	<code></code>
	<orcid>0000-0002-8272-914X</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
